Bunsua, Merly L.

HRN: 29-05-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2026
MUPIROCIN 2%, 15G (TUBE)
06/19/2026
06/26/2026
IV
2%
BID
Infected Breast Mass
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines